Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries

Blood

Volumn 108, Issue 1, 2006, Pages 292-296

  Landgren, Ola ^a   Engels, Eric A ^b   Caporaso, Neil E ^b   Gridley, Gloria ^b   Mellemkjaer, Lene ^b   Hemminki, Kari ^b   Linet, Martha S ^b   Goldin, Lynn R ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CASE CONTROL STUDY; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PERNICIOUS ANEMIA; POPULATION RESEARCH; PRIORITY JOURNAL; RHEUMATIC DISEASE; RISK FACTOR; SWEDEN;

EID: 33745611128     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-11-4620     Document Type: Article

References (40)

1. Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1975-2000. Bethesda, MD: National Cancer Institute; 2003.
2. Sgambati MT, Linet MS, Devesa S. Chronic lymphocytic leukemia: epidemiological, familial, and genetic aspects. Vol 2. 2nd ed. Basel, Switzerland: Marcel Dekker; 2001.
3. Goldin LR, Pfeiffer RM, Li X, Hemminki K. Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database. Blood. 2004;104:1850-1854.
4. Linet MS, Van Natta ML, Brookmeyer R, et al. Familial cancer history and chronic lymphocytic leukemia: a case-control study. Am J Epidemiol. 1989;130:655-664.
5. Cartwright RA, Bernard SM, Bird CC, et al. Chronic lymphocytic leukaemia: case control epidemiological study in Yorkshire. Br J Cancer. 1987;56:79-82.
6. Pottern LM, Linet M, Blair A, et al. Familial cancers associated with subtypes of leukemia and non-Hodgkin's lymphoma. Leuk Res. 1991;15:305-314.
7. Radovanovic Z, Markovic-Denic L, Jankovic S. Cancer mortality of family members of patients with chronic lymphocytic leukemia. Eur J Epidemiol. 1994;10:211-213.
8. Capalbo S, Trerotoli P, Ciancio A, Battista C, Serio G, Liso V. Increased risk of lymphoproliferative disorders in relatives of patients with B-cell chronic lymphocytic leukemia: relevance of the degree of familial linkage. Eur J Haematol. 2000;65:114-117.
9. Cannon-Albright LA, Thomas A, Goldgar DE, et al. Familiality of cancer in Utah. Cancer Res. 1994;54:2378-2385.
10. Polliack A, Lugassy G. Autoimmunity and autoimmune syndromes associated with and preceding the development of lymphoproliferative disorders. Leukemia. 1992;6(suppl 4):152-154.
11. Foon KA, Rai KR, Gale RP. Chronic lymphocytic leukemia: new insights into biology and therapy. Ann Intern Med. 1990;113:525-539.
12. Hamblin TJ, Oscier DG, Young BJ. Autoimmunity in chronic lymphocytic leukaemia. J Clin Pathol. 1986;39:713-716.
13. Hamblin TJ. Autoimmune disease and its management in chronic lymphocytic leukemia. In: Cheson BD, ed. Chronic lymphoid leukemias (2nd ed). New York, NY: Marcel Dekker, Inc; 2001:435-458.
14. Stevenson FK, Caligaris-Cappio F. Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood. 2004;103:4389-4395.
15. Zheng W, Linet MS, Shu XO, Pan RP, Gao YT, Fraumeni JF Jr. Prior medical conditions and the risk of adult leukemia in Shanghai, People's Republic of China. Cancer Causes Control. 1993;4:361-368.
16. Doody MM, Linet MS, Glass AG, et al. Leukemia, lymphoma, and multiple myeloma following selected medical conditions. Cancer Causes Control. 1992;3:449-456.
17. Linet MS, Cartwright RA. Chronic lymphocytic leukemia: epidemiology and etiologic findings. Nouv Rev Fr Hematol. 1988;30:353-357.
18. Linet MS, McCaffrey LD, Humphrey RL, et al. Chronic lymphocytic leukemia and acquired disorders affecting the immune system: a case-control study. J Natl Cancer Inst. 1986;77:371-378.
19. Conley CL, Misiti J, Laster AJ. Genetic factors predisposing to chronic lymphocytic leukemia and to autoimmune disease. Medicine (Baltimore). 1980;59:323-334.
20. Ekstrom K, Hjalgrim H, Brandt L, et al. Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives. Arthritis Rheum. 2003;48:963-970.
21. Landgren O, Bjorkholm M, Montgomery SM, et al. Personal and family history of autoimmune diabetes mellitus and susceptibility to young-adult-onset Hodgkin lymphoma. Int J Cancer. 2006;118:449-452.
22. Linet MS, McLaughlin JK, Harlow SD, Fraumeni JF. Family history of autoimmune disorders and cancer in multiple myeloma. Int J Epidemiol. 1988;17:512-513.
23. Mellemkjaer L, Alexander F, Olsen JH. Cancer among children of parents with autoimmune diseases. Br J Cancer. 2000;82:1353-1357.
24. Anonymous. Patientregistret 1987-1996: Kvalitet och innehåll [Swedish]. Stockholm, Sweden: EpC, National Board of Health and Welfare; 1998.
25. Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register: non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol. 1984;23:305-313.
26. Skarle A. Flergenerationsregistret. Stockholm, Sweden: Statistics Sweden, Population Statistics; 2001.
27. Hemminki K, Li X, Plna K, Granstrom C, Vaittinen P. The nation-wide Swedish family-cancer database - updated structure and familial rates. Acta Oncol. 2001;40:772-777.
28. Hemminki K, Vaittinen P. National database of familial cancer in Sweden. Genet Epidemiol. 1998;15:225-236.
29. Goldin LR, Pfeiffer RM, Gridley G, et al. Familial aggregation of Hodgkin lymphoma and related tumors. Cancer. 2004;100:1902-1908.
30. Landgren O, Linet MS, McMaster ML, Gridley G, Hemminki K, Goldin LR. Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study. Int J Cancer. 2006;118:3095-3098.
31. Mauro FR, Foa R, Cerretti R, et al. Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. Blood. 2000;95:2786-2792.
32. Parker AC, Bennett M. Pernicious anaemia and lymphoproliferative disease. Scand J Haematol. 1976;17:395-397.
33. Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet. 2005;366:155-168.
34. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med. 2005;352:804-815.
35. Hjalgrim H, Rasmussen S, Rostgaard K, et al. Familial clustering of Hodgkin lymphoma and multiple sclerosis. J Natl Cancer Inst. 2004;96:780-784.
36. Landgren O, Kerstann KF, Gridley G, et al. Re: Familial clustering of Hodgkin lymphoma and multiple sclerosis. J Natl Cancer Inst. 2005;97:543-544.
37. Thorselius M, Krober A, Murray F, et al. Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21 - using chronic lymphocytic leukemia independent of geographical origin and mutational status. Blood. 2006;107:2889-2894.
38. Messmer BT, Albesiano E, Messmer D, Chiorazzi N. The pattern and distribution of immunoglobulin VH gene mutations in chronic lymphocytic leukemia B cells are consistent with the canonical somatic hypermutation process. Blood. 2004;103:3490-3495.
39. Kienle D, Benner A, Krober A, et al. Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes. Blood. 2006;107:2090-2093.
40. Capello D, Guarini A, Berra E, et al. Evidence of biased immunoglobulin variable gene usage in highly stable B-cell chronic lymphocytic leukemia. Leukemia. 2004;18:1941-1947.